Role of Hck in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice

J Virol. 2001 Feb;75(4):1949-57. doi: 10.1128/JVI.75.4.1949-1957.2001.

Abstract

Soluble mediators such as interleukin-1beta, tumor necrosis factor alpha (TNF-alpha), and inducible nitric oxide synthase (iNOS) produced from activated macrophages play an important role in the destruction of pancreatic beta cells in mice infected with a low dose of the D variant of encephalomyocarditis (EMC-D) virus. The tyrosine kinase signaling pathway was shown to be involved in EMC-D virus-induced activation of macrophages. This investigation was initiated to determine whether the Src family of kinases plays a role in the activation of macrophages, subsequently resulting in the destruction of beta cells, in mice infected with a low dose of EMC-D virus. We examined the activation of p59/p56(Hck), p55(Fgr), and p56/p53(Lyn) in macrophages from DBA/2 mice infected with the virus. We found that p59/p56(Hck) showed a marked increase in both autophosphorylation and kinase activity at 48 h after infection, whereas p55(Fgr) and p56/p53(Lyn) did not. The p59/p56(Hck) activity was closely correlated with the tyrosine phosphorylation level of Vav. Treatment of EMC-D virus-infected mice with the Src kinase inhibitor, PP2, resulted in the inhibition of p59/p56(Hck) activity and almost complete inhibition of the production of TNF-alpha and iNOS in macrophages and the subsequent prevention of diabetes in mice. On the basis of these observations, we conclude that the Src kinase, p59/p56(Hck), plays an important role in the activation of macrophages and the subsequent production of TNF-alpha and nitric oxide, leading to the destruction of pancreatic beta cells, which results in the development of diabetes in mice infected with a low dose of EMC-D virus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blotting, Western
  • Cardiovirus Infections / immunology
  • Cardiovirus Infections / pathology
  • Cardiovirus Infections / virology*
  • Diabetes Mellitus, Type 1 / immunology
  • Diabetes Mellitus, Type 1 / pathology
  • Diabetes Mellitus, Type 1 / prevention & control
  • Diabetes Mellitus, Type 1 / virology*
  • Encephalomyocarditis virus / immunology
  • Encephalomyocarditis virus / pathogenicity*
  • Enzyme Activation
  • Islets of Langerhans / pathology
  • Macrophage Activation
  • Macrophages / immunology
  • Macrophages / metabolism
  • Macrophages / virology*
  • Male
  • Mice
  • Mice, Inbred DBA
  • Nitric Oxide Synthase / metabolism
  • Nitric Oxide Synthase Type II
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Protein-Tyrosine Kinases / metabolism*
  • Proto-Oncogene Proteins / antagonists & inhibitors
  • Proto-Oncogene Proteins / metabolism*
  • Proto-Oncogene Proteins c-hck
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Proto-Oncogene Proteins
  • Tumor Necrosis Factor-alpha
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type II
  • Nos2 protein, mouse
  • Protein-Tyrosine Kinases
  • Hck protein, mouse
  • Proto-Oncogene Proteins c-hck